Preclinical evaluation demonstrated dose-dependent anti-tumor efficacy in multiple models, suggesting clinical relevance.
Supplementary Fig S1. SQ3370 shows dose-dependent anti-tumor efficacy in multiple syngeneic tumor models
No takes yet. Share an insight, caveat, or question.
Srinivasan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: